September 20th 2024
Peptides are increasingly used in cosmeceuticals for their ability to enhance cellular communication and functionality in antiaging formulations.
Community Practice Connections™: 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
Dermalorian™ Webinar Series on Moderate to Severe Atopic Dermatitis
November 21, 2024 - December 5, 2024
View More
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Botox 'impressive' for mild dermatochalasis
August 1st 2005New Orleans — Lateral infrabrow injection of botulinum toxin type A (Botox/Botox Cosmetic, Allergan) may be considered as a less invasive alternative to blepharoplasty in patients seeking treatment for mild-to-moderate dermatochalasis, says Joel L. Cohen, M.D.
Today's fillers: Carefully consider product choices for patients to achieve 'customized' outcomes
August 1st 2005The broad range of fillers available today allows dermatologists to target any depth of the skin and treat an array of cosmetic defects. Now, according to Kevin Pinski, M.D., the emphasis is on indications, and analyzing the skin of each patient to determine which fillers would be best and then tailoring a treatment plan that's just right for that person.
Seeking wound healing research funding?
August 1st 2005Bethesda, Md. — A variety of funding opportunities are available for research into improving the processes of wound healing. The National Institutes of Health (NIH) is supporting clinical research that is interdisciplinary, multi-phased and translational — going from bench to bedside.
Inadequate SPF demands better UVA protection
August 1st 2005Vienna, Austria — In a continuation of a decade-long debate, the importance of the immunoprotection factor (IPF) and its role in sun protection is again central among the world's photobiological research community who advocate revising the current sun protection factor (SPF) rationale with the reality of its ineffectiveness.
Thermage, Syneron resolve suits alleging patent infringement
July 5th 2005National report -- Medical-device developers and manufacturers Thermage Inc. and Syneron have reached an agreement that resolves lawsuits claiming that Syneron infringed certain patents held by Thermage and that Thermage infringed a patent held by Syneron.
Execs see cosmetic surgery as a way to boost careers
July 5th 2005National report -- A survey conducted among female and male executives reveals that more than 25 percent of women respondents and 20 percent of the males would consider cosmetic surgery as a means by which to improve their career aspirations.
Tear trough deformities benefit from hyaluronic acid
July 1st 2005New Orleans — Hyaluronic acid is a satisfactory alternative for correction of tear trough deformity in a diverse cross section of people, and an excellent choice for tear trough volume restoration in select candidates. The best candidate is a younger person who has thicker skin and minimal to moderate volume loss, according to New York City cosmetic surgeon Haideh Hirmand, M.D., plastic surgery clinical assistant professor of surgery, Cornell Medical College.
Clindamycin-tretinoin combo effective for acne
July 1st 2005National Report - Pooled results from two phase 3 clinical trials demonstrate the efficacy and safety of an investigational acne treatment combining clindamycin and tretinoin in a hydrogel base (Velac, Connetics), James J. Leyden, M.D., reported at the 63rd Annual Meeting of the American Academy of Dermatology.
Botox dosing, techniques refined to target individual
July 1st 2005San Diego — For cosmetic facial problems, Botox (botulinum toxin A, Allergan) is no longer a stand-alone, one-size-fits-all treatment. Increasingly, doctors are modifying doses based on individual patient needs and combining Botox with soft tissue fillers.
Psoriasis: Treatment combinations require blend of art, science
July 1st 2005Dallas - Most patients with moderate to severe psoriasis are best treated with a combination of topical, phototherapy and/or systemic agents that can be used in a variety of sequences, says Alan Menter, M.D., chairman, division of dermatology, Baylor University Medical Center.
Injectable silicone shows new promise
July 1st 2005National report — A variety of options are available to treat HIV facial lipoatrophy, but, currently, off-label use of highly purified, medical grade 1000-centistoke silicone oil (Silikon 1000, Alcon Laboratories) as a permanent filler material seems to best fulfill the need for persistent, safe, cost-effective and natural-appearing correction, said Derek H. Jones, M.D., at the 63rd Annual Meeting of the American Academy of Dermatology.
Economics focus of topical acne treatment comparison
July 1st 2005National report — Among topical medications for treating mild-to-moderate acne, antibiotics are the most cost-effective therapy for inflammatory acne while retinoids are the most cost-effective for clearing non-inflammatory lesions, according to the results of a pharmacoeconomic evaluation reported by Stefan Weiss, M.D., at the 63rd Annual Meeting of the American Academy of Dermatology.
Phototherapy garners interest for acne tx
July 1st 2005New Orleans — While treatment of acne with lasers and light sources is here to stay, phototherapy for acne is still an evolving field, and further research is needed to optimize outcomes, according to David J. Goldberg, M.D., J.D., who spoke at the 63rd Annual Meeting of the American Academy of Dermatology.
Chemical peels: Cost-effective facial rejuvenation
July 1st 2005Chances are that cost-effective chemical peels will always be at the front of the dermatologist's facial rejuvenation bag of tricks. But these peels should no longer be viewed in a vacuum, according to Harold J. Brody, M.D., clinical professor of dermatology, Emory University, Atlanta.
Combined therapies produce 'total care'
July 1st 2005San Diego — While the viability of the Nd:YAG laser has made nonablative resurfacing a real alternative for many cosmetic surgeons, physicians today are realizing the necessity of supplementing this treatment with a variety of other devices to address diverse conditions.
Tear trough deformities benefit from hyaluronic acid
July 1st 2005New Orleans — Hyaluronic acid is a satisfactory alternative for correction of tear trough deformity in a diverse cross section of people, and an excellent choice for tear trough volume restoration in select candidates. The best candidate is a younger person who has thicker skin and minimal to moderate volume loss, according to New York City cosmetic surgeon Haideh Hirmand, M.D., plastic surgery clinical assistant professor of surgery, Cornell Medical College.